In the present study, LAG3-positive T cells, which are associated with a better prognosis after anti-PD-1 therapy, might have included an exhausted subset that is tumour-specific and can be reinvigorated by PD-1/PD-L1 blockade. The gene discussed is CD274; the disease is neoplasm.